Skip to content

Analysis of the Effect of Baduanjin Training on Exercise Tolerance in Patients with Coronary Heart Disease and Hypertension

Analysis of the Effect of Baduanjin Training on Exercise Tolerance in Patients with Coronary Heart Disease and Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072332
Enrollment
Unknown
Registered
2023-06-09
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease and hypertension

Interventions

intervention group:conventional therapy and Baduanjin exercise
control group:conventional therapy

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. patients should be older than 40 years and younger than 75 years. 2. if there is cardiac insufficiency, the New York Heart Association (NYHA) classifies it as Class II-III. 3. there are no complications after operation. 4. each of the following items was considered as low risk in the risk stratification of cardiac rehabilitation of coronary heart disease: ST segment depression in ECG and no clinical manifestation of myocardial ischemia after exercise, no complicated arrhythmia; There were no complications after percutaneous Coronary stent, no abnormal Hemodynamics, no clinical anxiety and depression, and no abnormal myocardial markers such as myocardial enzymes. 5. patients agreed to be enrolled, signed the informed consent form and could persist for at least 3 months.

Exclusion criteria

Exclusion criteria: Patients with severe heart, liver and kidney diseases, Secondary hypertension or history of mental illness, with disturbance of consciousness or cognitive function, or unable to cooperate in completing the research were excluded.

Design outcomes

Secondary

MeasureTime frame
systolic blood pressure;diastolic blood pressure;general anxiety disorder-7;patient health questionnaire-9;Pittsburgh sleep quality assessment scale;

Primary

MeasureTime frame
peak oxygen uptake;

Countries

China

Contacts

Public ContactZhaoqi Huang

The Third Affiliated Hospital of Guangzhou Medical University

zhaoqihuang2007@163.com+86 138 0275 0240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026